PAVmed/$PAVM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About PAVmed
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
Ticker
$PAVM
Sector
Primary listing
Employees
39
Headquarters
Website
PAVmed Metrics
BasicAdvanced
$8.1M
0.56
$0.83
1.08
-
Price and volume
Market cap
$8.1M
Beta
1.08
52-week high
$1.68
52-week low
$0.30
Average daily volume
220K
Financial strength
Current ratio
0.522
Quick ratio
0.417
Long term debt to equity
6.264
Total debt to equity
29.632
Interest coverage (TTM)
-1,035.58%
Profitability
EBITDA (TTM)
-26.553
Gross margin (TTM)
-47.75%
Net profit margin (TTM)
7,144.80%
Operating margin (TTM)
-2,639.71%
Revenue per employee (TTM)
$30,000
Management effectiveness
Return on assets (TTM)
-40.40%
Return on equity (TTM)
1,066.81%
Valuation
Price to earnings (TTM)
0.563
Price to revenue (TTM)
6.067
Price to book
0.73
Price to tangible book (TTM)
0.73
Price to free cash flow (TTM)
-0.551
Free cash flow yield (TTM)
-181.34%
Free cash flow per share (TTM)
-0.85
Growth
Revenue change (TTM)
-73.36%
Earnings per share change (TTM)
-110.31%
3-year revenue growth (CAGR)
13.97%
3-year earnings per share growth (CAGR)
-60.22%
What the Analysts think about PAVmed
Majority rating from 4 analysts.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for PAVmed stock?
PAVmed (PAVM) has a market cap of $8.1M as of August 23, 2025.
What is the P/E ratio for PAVmed stock?
The price to earnings (P/E) ratio for PAVmed (PAVM) stock is 0.56 as of August 23, 2025.
Does PAVmed stock pay dividends?
No, PAVmed (PAVM) stock does not pay dividends to its shareholders as of August 23, 2025.
When is the next PAVmed dividend payment date?
PAVmed (PAVM) stock does not pay dividends to its shareholders.
What is the beta indicator for PAVmed?
PAVmed (PAVM) has a beta rating of 1.08. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.